Diagnostic Enzymes & IVD
Blood Glucose Monitoring Enzyme Solutions
Glucose oxidase-based biorecognition, immobilization, and sensor characterization for point-of-care, continuous, and wearable glucose monitoring programs.
What This Service Covers
Blood glucose monitoring devices, often called blood glucose meters, measure the amount of glucose in a small blood sample using a handheld meter and test strips, and are widely used in both home and health care settings. The sensing chemistry at the heart of most such systems is enzymatic: glucose oxidase (GOx) catalyzes the oxidation of glucose to gluconic acid and hydrogen peroxide, and the resulting electron transfer or peroxide generation is converted into a measurable signal that scales with glucose concentration.
Our service supports teams developing that chemistry into a manufacturable, qualified sensor. We work on the enzyme layer, the immobilization chemistry, the transducer interface, and the analytical performance package that a diagnostic product needs before design transfer. Engagements are scoped case by case against the intended sample matrix, readout modality, and regulatory pathway the customer is pursuing.
Glucose Oxidase Enzyme Layer
Glucose oxidase is the biorecognition element that gives the sensor its selectivity for glucose over other sugars and interferents. We support enzyme sourcing, activity assessment, and engineering of GOx variants where the immobilization chemistry calls for it.
- GOx activity and stability assessment under intended use conditions
- Variant engineering support, including engineered cysteine residues for directed conjugation to the transducer surface
- Compatibility screening against the chosen immobilization chemistry
Immobilization and Transducer Interface
The enzyme must be anchored to the electrode or optical transducer in a way that preserves activity and produces a reproducible signal. Immobilization strategy is selected against the platform rather than applied as a fixed recipe.
- Crosslinker, polymer, and nanomaterial-based immobilization routes
- Screen-printed and flexible electrode integration
- Optical transducer conjugation for fluorescence-based readout
Analytical Characterization
A glucose sensor is only as useful as its measured performance envelope. We characterize sensitivity, detection limit, linear range, response time, and stability so that the sensor's claims are supported by data rather than assumption.
- Sensitivity and limit of detection determination
- Linear range optimization, including diffusion-limiting membrane design
- Stability, drift, and interference resistance testing
Platform and Scope Options
Glucose monitoring programs differ in sample matrix, readout modality, and whether the device is a single-use strip, a continuous monitor, or a wearable patch. The table below describes the parameters that are typically customized per project; the specific scope, analytics, and validation depth for any engagement are defined in the project statement of work after consultation.
Reported performance figures in the literature vary widely by platform and are cited here as background for what is achievable in principle, not as project-dependent delivery targets for any specific program.
| Parameter | Typical project scope | Common platform examples | Notes |
|---|---|---|---|
| Sample matrix | Blood, interstitial fluid, sweat, or cell culture media, as scoped | Capillary blood, subcutaneous, sweat patch, microfluidic | Matrix drives dilution, membrane, and interference strategy |
| Transduction modality | Electrochemical or optical, selected per project | Amperometric electrodes, SWCNT near-infrared fluorescence | Readout electronics and calibration approach follow from this choice |
| Immobilization chemistry | Crosslinker, polymer, or nanomaterial route, scoped per project | Maleimide crosslinkers, conjugated polymers, chitosan, Nafion | Selected for enzyme retention, activity, and manufacturability |
| Diffusion-limiting membrane | Applied when linear range extension is required | Polyurethane, Nafion, or comparable outer layers | Membrane design trades sensitivity against upper linear limit |
| Linear range target | Defined against the intended clinical or application range | Physiological blood range; lower ranges for sweat or cell culture | Range and sensitivity are co-optimized, not set independently |
| Stability testing | Duration and storage conditions scoped per project | Refrigerated buffer storage, accelerated aging, on-body wear | Stability claims are supported by the project's own data |
| Readout integration | Wired, wireless, or standalone reader, as scoped | Bluetooth Low Energy modules, miniaturized optical readers | Firmware and app integration handled as a defined workstream |
| Documentation | Method descriptions, data packages, and transfer records as scoped | Development reports, characterization datasets | Content and format agreed at project initiation |
How an Engagement Works
Projects move from a defined sensing concept to a characterized sensor element through a sequence of design, build, and test stages. Each stage produces documentation that feeds the next, so that performance claims remain traceable to the underlying measurements.
Define the sensing requirement
We start from the intended sample matrix, required measurement range, readout modality, and device format, then translate those into a target specification for the enzyme layer and transducer.
Select and prepare the enzyme layer
Glucose oxidase is selected or engineered for the chosen immobilization route, with activity and stability assessed under conditions that approximate the intended use environment.
Immobilize onto the transducer
The enzyme is anchored to the electrode or optical surface using the agreed chemistry, and the resulting interface is checked for coverage, retained activity, and reproducibility across devices.
Apply the diffusion-limiting membrane
Where the target range requires it, an outer membrane is applied to extend linearity and reduce interference, with membrane thickness and composition treated as tunable design variables.
Customization and Design Choices
Glucose oxidase sensors are not a single product. The design space spans enzyme form, immobilization chemistry, transducer material, membrane architecture, and readout electronics, and the right combination depends on the device the customer intends to build.
The options below describe the dimensions we routinely customize. Specific selections are made jointly during scoping and recorded in the project statement of work.
GOx Form and Engineering
Native glucose oxidase, engineered variants, or catalytically inactive apo forms can be considered depending on whether the readout relies on catalytic turnover or on binding-induced signal change.
- Engineered cysteine variants for directed thiol conjugation
- Apo-enzyme options for non-consuming optical sensing schemes
- Activity retention screening across candidate lots
Immobilization Chemistry
The anchoring chemistry determines how much activity survives immobilization and how stable the interface remains over the device lifetime. We screen candidate chemistries against the chosen transducer.
- Maleimide and related crosslinker conjugation
- Conjugated polymer and chitosan support matrices
- Nanomaterial scaffolds including carbon nanotube platforms
Diffusion-Limiting Architecture
An outer diffusion-limiting layer is commonly used to extend the linear range and reduce the impact of interferents, at some cost to absolute sensitivity. Membrane design is treated as an explicit optimization variable.
- Polyurethane and Nafion outer layers
- Thickness and permeability tuning against the target range
- Interference and fouling resistance evaluation
Analytical Performance Package
The performance package defines what the sensor can and cannot claim. Each parameter below is measured against the project's own device and conditions; the literature values shown are illustrative of what has been reported for comparable platforms and are not delivery commitments.
Where a parameter is not relevant to a given program, it is omitted from the scope rather than reported as a nominal value.
| Parameter | What is measured | Reported examples in literature | Project treatment |
|---|---|---|---|
| Sensitivity | Sensitivity is the signal change per unit glucose concentration, normalized to electrode area where applicable. | Values in the range of roughly 12 µA mM⁻¹ cm⁻² have been reported for electrochemical GOx platforms. | Measured on the project device; target set during scoping |
| Limit of detection | Lowest glucose concentration distinguishable from blank at a defined confidence | Micromolar-level detection has been reported for nanostructured GOx electrodes | Determined by the project's own calibration and noise data |
| Linear range | Concentration span over which response is proportional to glucose | Ranges spanning roughly 1–30 mM have been reported for membrane-modified sensors | Optimized against the intended sample matrix and clinical range |
| Response time | Time to reach a defined fraction of steady-state signal after a step change | Sub-minute responses have been reported for thin-film enzyme layers | Constrained by membrane thickness and diffusion design |
| Stability and drift | Change in response over storage or continuous operation | Storage stability on the order of weeks to a month has been reported for buffered conditions. | Tested under the project's intended storage and use conditions |
| Interference resistance | Response to ascorbate, urate, acetaminophen, and other electroactive species | Membrane and permselective layers are commonly used to suppress interferents | Screened against the interferent panel relevant to the sample matrix |
| Reproducibility | Device-to-device and lot-to-lot variation in response | Not uniformly reported; depends heavily on fabrication route | Assessed across the batch sizes defined in the project scope |
Quality Control and Transfer
A sensor chemistry that performs in a development lab still has to survive fabrication, storage, and use. Our QC and transfer work is aimed at making the performance envelope reproducible rather than demonstrating a single good device.
Calibration and stability testing form the backbone of this work: calibration establishes the relationship between signal and glucose concentration, and stability testing establishes how long that relationship holds.
Calibration and Range Verification
Calibration protocols are defined against the intended measurement range, with verification runs confirming that the sensor responds proportionally across that span and remains within defined tolerances.
- Calibration curve generation and acceptance criteria
- Range verification at the low and high ends of intended use
- Re-calibration interval assessment for continuous formats
Stability and Shelf-Life Testing
Stability testing examines how enzyme activity, membrane integrity, and signal output change over time under defined storage and operating conditions, including accelerated conditions where appropriate.
- Storage stability under defined temperature and buffer conditions
- Continuous-operation drift monitoring
- On-body or in-use stability for wearable formats
Method Documentation and Transfer
The characterization work is compiled into method descriptions and data packages that support internal transfer, scale-up discussions, and regulatory documentation planning.
- Written method descriptions for the enzyme and immobilization steps
- Characterization datasets with traceable raw data
- Transfer support for the customer's manufacturing or development team
Applications and Formats
The same glucose oxidase sensing principle serves several device categories, each with its own constraints on sample volume, sensor lifetime, and readout hardware. The table below maps common application formats to the design considerations that typically dominate.
Format selection is made early in scoping because it constrains nearly every downstream decision, from membrane chemistry to electronics.
| Application format | Typical sample | Dominant design constraints | Relevant sensing approach |
|---|---|---|---|
| Point-of-care test strip | Capillary whole blood | Single-use cost, hematocrit effects, fast response | Screen-printed electrochemical GOx electrode |
| Continuous glucose monitor | Interstitial fluid | Multi-day stability, drift, biocompatibility | Implanted or subcutaneous enzymatic electrode |
| Wearable sweat patch | Sweat | Very low analyte concentration, mechanical flexibility | Flexible electrochemical or optical GOx sensor |
| Optical nanosensor | Biological fluids and tissue | Tissue transparency, reversibility, photostability | GOx-functionalized single-walled carbon nanotubes |
| Microfluidic cell culture monitoring | Culture medium | Miniaturization, sterility, long-term drift | Miniaturized enzymatic optical sensor element |
Why Enzyme-Based Sensing
Enzymatic glucose sensing remains the dominant approach in commercial blood glucose monitoring because glucose oxidase offers high selectivity for glucose and a well-understood catalytic mechanism that converts a chemical event into an electronic or optical signal.
Alternative approaches exist, including non-enzymatic electrocatalytic sensors and enzyme-free affinity chemistries, and each has trade-offs in selectivity, stability, and manufacturability. We work within the enzymatic route and can discuss where it fits relative to those alternatives during scoping.
Working With Our Team
Engagements begin with a scoping discussion covering the intended device format, sample matrix, target measurement range, and the stage of development the customer is at. From there we define the workstreams, deliverables, and documentation that fit the program.
Because glucose sensor programs vary widely in maturity, scope is set case by case rather than from a fixed package. A team that already has a working electrode chemistry may need only characterization and stability work; a team starting from a sensing concept may need the full sequence from enzyme selection through transfer documentation.
FAQ
How does glucose oxidase actually generate the signal in a glucose sensor?
Glucose oxidase catalyzes the oxidation of glucose to gluconic acid and hydrogen peroxide. In an electrochemical sensor, the peroxide or the electron transfer at the electrode is converted into a current proportional to glucose concentration. In an optical sensor, the enzyme is coupled to a transducer such as a fluorescent nanomaterial whose emission changes with glucose binding or reaction, so the same catalytic chemistry produces a measurable optical signal instead.
Why is a diffusion-limiting membrane used, and does it reduce sensitivity?
A diffusion-limiting outer layer, commonly a polyurethane or Nafion film, restricts how quickly glucose reaches the enzyme layer. This extends the upper end of the linear range and reduces the impact of interferents, which is important for physiological glucose concentrations. It does typically reduce absolute sensitivity, so membrane thickness and permeability are treated as design variables that are optimized against the target range rather than fixed in advance.
Can the same enzyme chemistry support continuous or wearable monitoring?
Yes. Glucose oxidase-based sensors have been demonstrated in continuous monitoring formats, including screen-printed electrochemical platforms with wireless readout and optical nanosensors for continuous glucose imaging. Continuous and wearable formats add constraints around stability over days of operation, drift, biocompatibility, and power consumption, so the enzyme and membrane design usually needs to be adapted rather than reused unchanged from a single-use strip.
How is sensor performance verified before we commit to a design?
Performance is verified through calibration and stability testing against the intended measurement range. Calibration establishes the signal-to-concentration relationship and confirms proportionality across the range, while stability testing examines how that relationship holds over storage and continuous operation. Sensitivity, detection limit, response time, and interference resistance are measured on the project's own devices, and the results are compiled into a characterization package for review.
Do you work with non-enzymatic or dehydrogenase-based glucose sensing?
Our standard scope is glucose oxidase-based sensing chemistry. Non-enzymatic approaches rely on direct electrocatalytic oxidation at metal or metal oxide surfaces and involve no enzyme immobilization, while dehydrogenase-based systems use different cofactors and electron transfer strategies. Those are distinct chemistries with different design considerations, so they fall outside this offering and would need to be discussed separately.
References
- Jin X, Li G, Xu T, et al. Fully integrated flexible biosensor for wearable continuous glucose monitoring. Biosensors & bioelectronics. 2022;196:113760. View on PubMed
- Xiao Y, Hou L, Wang M, et al. Noninvasive glucose monitoring using portable GOx-Based biosensing system. Analytica chimica acta. 2024;1287:342068. View on PubMed
- Zubkovs V, Wang H, Schuergers N, et al. Bioengineering a glucose oxidase nanosensor for near-infrared continuous glucose monitoring. Nanoscale advances. 2022;4(11):2420-2427. View on PubMed
- Kim S, Malik J, Seo JM, et al. Subcutaneously implantable electromagnetic biosensor system for continuous glucose monitoring. Scientific reports. 2022;12(1):17395. View on PubMed
- Kim JH, Choi H, Park CS, et al. Diboronic-Acid-Based Electrochemical Sensor for Enzyme-Free Selective and Sensitive Glucose Detection. Biosensors. 2023;13(2). View on PubMed
- Nishitani S, Tran T, Puglise A, et al. Engineered Glucose Oxidase-Carbon Nanotube Conjugates for Tissue-Translatable Glucose Nanosensors. Angewandte Chemie (International ed. in English). 2024;63(8):e202311476. View on PubMed
Scope Your Glucose Sensor Program
Share your intended device format, sample matrix, and target measurement range, and we will outline the enzyme, immobilization, and characterization workstreams that fit your development stage.